ReAlta Life Sciences, Inc. is a clinical stage biotech company dedicated to harnessing the power of the immune system through its EPICC technology platform, comprised of a family of over 160 engineered peptides, to address life-threatening medical needs. The peptide family leverages one billion years of evolution that has enabled the human astrovirus to inhibit components of the innate immune system. This novel class of therapeutics exploits the virus' dual targeting approach and enables the rebalancing of complement and inflammatory processes in the body. The company’s pipeline is led by RLS-0071, which has been granted Orphan Drug Designation by the U.S. Food and Drug Administration and European Medicines Agency for the treatment of hypoxic-ischemic encephalopathy (HIE) in neonates, and is also being developed as a treatment for acute lung injury secondary to COVID-19. The company launched in 2018, and is located in Norfolk, Virginia. For more information, please visit www.realtalifesciences.com.
Location: United States, Minnesota, Norfolk
Employees: 11-50
Phone: +1 757-901-0460
Total raised: $34M
Founded date: 2018
Funding Rounds 2
| Date | Series | Amount | Investors |
| 28.04.2021 | - | $20M | - |
| 30.04.2020 | - | $14M | - |
Mentions in press and media 9
| Date | Title | Description |
| 08.06.2021 | ReAlta Life Sciences Receives $3.2 Million Grant from Virginia Catalyst to Accelerate Trial for the Treatment of Acute Lung Injury Due to COVID-19 | ReAlta Life Sciences (“ReAlta”), Inc., a company addressing life-threatening diseases through harnessing the power of the immune system, today announced that it has received a $3.2 million grant award from The Virginia Catalyst, also known ... |
| 28.04.2021 | ReAlta Life Sciences Closes $20 Million Series A3 Financing to Advance Multiple Programs into Phase 2 Clinical Trials | ReAlta Life Sciences, Inc., today announced that the Company has successfully closed a Series A3 financing of $20 million. The financing was led by Marathon Pharma, with support from existing Series A investors and new, undisclosed investor... |
| 28.04.2021 | ReAlta Life Sciences Closes $20 Million Series A3 Financing | NORFOLK, Va.--(BUSINESS WIRE)--ReAlta Life Sciences, Inc., today announced that the Company has successfully closed a Series A3 financing of $20 million. The financing was led by Marathon Pharma, with support from existing Series A investor... |
| 28.04.2021 | ReAlta Life Sciences Raises $20M in Series A3 Financing | ReAlta Life Sciences, Inc., a Norfolk, Va.-based clinical stage biotech company, closed a $20m Series A3 financing. The round was led by Marathon Pharma, with participation from existing investors and new, undisclosed investors. The company... |
| 04.01.2021 | The Richmond innovation stories that defined 2020 | Sure, 2020 was the year that “doomscrolling” became a thing, but there was good news, too. In Richmond, we saw startups pivot to join the fight against Covid-19. Others took big steps forward in their growth journeys, launching new platform... |
| 29.12.2020 | The Richmond region's biggest funding stories of 2020 | Through shutdowns and social distancing, 2020 saw some of Richmond’s startups secure significant funding commitments. And perhaps it’s no surprise, given the way one story dominated the headlines, that each of this year’s most impressive fu... |
| 30.04.2020 | ReAlta Life Sciences Completes $14M Series A2 Financing | ReAlta Life Sciences, Inc., a Norfolk, Va.-based biotech company, closed a Series A2 financing of $14m, bringing the total Series A financing to $26m. The round was led by Children’s Research Holdings and Marathon Pharma, as well as additio... |
| 21.04.2020 | ReAlta Life Sciences Closes $14 Million Series A2 Financing | ReAlta Life Sciences, Inc., today announced that it has successfully closed an oversubscribed Series A2 financing of $14 million, bringing the total Series A financing to $26 million. The financings were led by Children’s Research Holdings ... |
| 10.02.2020 | The Hampton Roads Tech Ecosystem at a Glance | This is part of our Inno on the Road Series, where we explore and showcase a neighboring ecosystem. Inno on the Road: Hampton Roads, which will feature a couple new stories a month and an event in May, is presented by BDO. With a tangled we... |